Trial · NCT00872989
Results by group178
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 178
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Progression Free Survival (PFS) | Arm I: Docetaxel | 3.5 | 95% Confidence Interval 2.3 to 4.6 | months | |
| Progression Free Survival (PFS) | Arm II: Docetaxel + Vandetanib | 3.0 | 95% Confidence Interval 1.6 to 4.3 | months | |
| Number of Participants With a Complete Response, Partial Response, Stable Disease, or Increasing Disease | Arm I: Docetaxel | Complete Response | 0 | participants | |
| Number of Participants With a Complete Response, Partial Response, Stable Disease, or Increasing Disease | Arm II: Docetaxel + Vandetanib | Complete Response | 0 | participants | |
| Number of Participants With a Complete Response, Partial Response, Stable Disease, or Increasing Disease | Arm I: Docetaxel | Partial Response | 5 | participants | |
| Number of Participants With a Complete Response, Partial Response, Stable Disease, or Increasing Disease | Arm II: Docetaxel + Vandetanib | Partial Response | 6 | participants | |
| Number of Participants With a Complete Response, Partial Response, Stable Disease, or Increasing Disease | Arm I: Docetaxel | Unconfirmed Complete Response | 1 | participants | |
| Number of Participants With a Complete Response, Partial Response, Stable Disease, or Increasing Disease | Arm II: Docetaxel + Vandetanib | Unconfirmed Complete Response | 0 | participants | |
| Number of Participants With a Complete Response, Partial Response, Stable Disease, or Increasing Disease | Arm I: Docetaxel | Unconfirmed Partial Response | 2 | participants | |
| Number of Participants With a Complete Response, Partial Response, Stable Disease, or Increasing Disease | Arm II: Docetaxel + Vandetanib | Unconfirmed Partial Response | 2 | participants | |
| Number of Participants With a Complete Response, Partial Response, Stable Disease, or Increasing Disease | Arm I: Docetaxel | Stable/No Response | 19 | participants | |
| Number of Participants With a Complete Response, Partial Response, Stable Disease, or Increasing Disease | Arm II: Docetaxel + Vandetanib | Stable/No Response | 17 | participants | |
| Number of Participants With a Complete Response, Partial Response, Stable Disease, or Increasing Disease | Arm I: Docetaxel | Increasing Disease | 23 | participants | |
| Number of Participants With a Complete Response, Partial Response, Stable Disease, or Increasing Disease | Arm II: Docetaxel + Vandetanib | Increasing Disease | 20 | participants | |
| Number of Participants With a Complete Response, Partial Response, Stable Disease, or Increasing Disease | Arm I: Docetaxel | Symptomatic Deterioration | 0 | participants | |
| Number of Participants With a Complete Response, Partial Response, Stable Disease, or Increasing Disease | Arm II: Docetaxel + Vandetanib | Symptomatic Deterioration | 1 | participants | |
| Number of Participants With a Complete Response, Partial Response, Stable Disease, or Increasing Disease | Arm I: Docetaxel | Assessment Inadequate | 7 | participants | |
| Number of Participants With a Complete Response, Partial Response, Stable Disease, or Increasing Disease | Arm II: Docetaxel + Vandetanib | Assessment Inadequate | 6 | participants | |
| Overall Survival | Arm I: Docetaxel | 18 | 95% Confidence Interval 13.7 to 26.1 | months | |
| Overall Survival | Arm II: Docetaxel + Vandetanib | 14 | 95% Confidence Interval 9.9 to 19.7 | months |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00872989/results